Naghmeh Tebyanian MD in Lanham, Maryland

Medical School: George Washington University School Of Medicine
Graduation Year: 1993
The Primary Medical Specialty for Naghmeh Tebyanian MD is listed as: Cardiovascular Disease (cardiology)
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 31
PAC (PECOS ID)#: 1052202314
NPI #: 1659310043
NPI Created On: 06/04/2006
NPI Last Updated Listed as: 03/18/2015
Primary Taxonomy Code: 207RC0000X
License Number:
0101054906
Listed Gender: Female

---

Forms of insurance accepted by include, but are not limited to:

• CareFirst BlueChoice, Inc.
• Humana
• Group Hospitalization and Medical Services Inc.
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English,Farsi, Persian, Spanish, Turkish, Farsi, Persian, Spanish, Turkish, English.

---

Services and Procedures include:

1. External ekg recording for more than 48 hours up to 21 days
2. Review and interpretation of external ekg recording for more than 48 hours up to 21 days
3. Nuclear medicine study of vessels of heart using drugs or exercise multiple studies
4. Routine ekg using at least 12 leads including interpretation and report
5. Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician supervision, interpretation, and report
6. Heart rhythm tracing, analysis, and interpretation of 48-hour ekg
7. Heart rhythm tracing, computer analysis, and interpretation of patient-triggered events greater than 24-hour ekg up to 30 days
8. Heart rhythm tracing, computer analysis, physician prescribed transmission of patient-triggered events greater than 24-hour ekg up to 30 days
9. Evaluation, testing, and programming adjustment of permanent dual lead pacemaker system with physician analysis, review, and report
10. Remote evaluations of single, dual, or multiple lead pacemaker system with qualified health care professional analysis, review, and report, up to 90 days
11. Remote evaluations of single, dual, or multiple lead pacemaker system or implantable defibrillator system with technician review, support and distribution of results, up to 90 days
12. Remote evaluations of heart rhythm monitor system implanted under skin with qualified health care professional analysis, review, and report, up to 30 days
13. Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function
14. Ultrasound examination and continuous monitoring of the heart performed during rest, exercise, and/or drug-induced stress with interpretation and report
15. New patient office or other outpatient visit, typically 45 minutes
16. Established patient office or other outpatient visit, typically 15 minutes
17. Established patient office or other outpatient, visit typically 25 minutes
18. Technetium tc-99m tetrofosmin, diagnostic, per study dose
19. Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec
20. Injection, regadenoson, 0.1 mg

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).